What is the meaning of PASAT rejection in multiple sclerosis?-Reference-Cited by-同舟云学术

What is the meaning of PASAT rejection in multiple sclerosis?

Published:2019-04-12 Issue:6 Volume:139 Page:559-562
ISSN:0001-6314
Container-title:Acta Neurologica Scandinavica
language:en
Short-container-title:Acta Neurol Scand

Author:

Cortés‐Martínez Ana¹,Matias‐Guiu Jordi A.¹^ORCID,Pytel Vanesa¹^ORCID,Montero Paloma¹,Moreno‐Ramos Teresa¹,Matías‐Guiu Jorge¹

Affiliation:

1. Department of Neurology San Carlos Institute for Health Research (IdISSC), Universidad Complutense de Madrid Madrid Spain

Publisher

Wiley

Subject

Neurology (clinical),Neurology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ane.13090

Reference12 articles.

1. SM Rao A Manual for the Brief Repeatable Battery of Neuropsychological Tests in Multiple Sclerosis 1990 Medical College of Wisconsin Milwaukee 1696

2. Minimal Neuropsychological Assessment of MS Patients: A Consensus Approach

3. Cognitive screening tools in multiple sclerosis revisited: sensitivity and specificity of a short version of Rao’s Brief Repeatable Battery

4. Cognition in multiple sclerosis

5. A comprehensive review of the Paced Auditory Serial Addition Test (PASAT)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of virtual reality-based rehabilitation on cognitive function and mood in multiple sclerosis: A systematic review and meta-analysis of randomized controlled trials;Multiple Sclerosis and Related Disorders;2024-07

2. THE ROLE OF BRAIN-DERIVED NEUROTROPHIC FACTOR AND INTERLEUKIN-6 IN THE FORMATION OF COGNITIVE IMPAIRMENTS IN PATIENTS WITH MULTIPLE SCLEROSIS;Bulletin of Problems Biology and Medicine;2024

3. Multi-Disease Validation of the RUDAS for Cognitive Screening in Alzheimer’s Disease, Parkinson’s Disease, and Multiple Sclerosis;Journal of Alzheimer's Disease;2023-01-17

4. Validation of a brief cross-cultural cognitive screening test in Multiple Sclerosis;Multiple Sclerosis and Related Disorders;2022-11

5. Improved prediction of early cognitive impairment in multiple sclerosis combining blood and imaging biomarkers;Brain Communications;2022-07-04